TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TERT
aberrancies: a screening tool for malignancy in follicular thyroid tumours
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 25, Issue 7, Pages 723-733
Publisher
Bioscientifica
Online
2018-04-25
DOI
10.1530/erc-18-0050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TERTpromoter mutations in thyroid cancer
- (2016) Rengyun Liu et al. ENDOCRINE-RELATED CANCER
- Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
- (2016) Tiantian Liu et al. Genes
- Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
- (2015) Dong-Sheng Huang et al. EUROPEAN JOURNAL OF CANCER
- Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology
- (2015) Emmanuel Labourier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
- (2015) Yuri E. Nikiforov et al. THYROID
- TERTpromoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA
- (2014) Na Wang et al. CANCER
- Value of thyroid specific peroxidase and Ki-67 stains in preoperative cytology for thyroid follicular tumors
- (2014) Junko Maruta et al. DIAGNOSTIC CYTOPATHOLOGY
- TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
- (2014) Miguel Melo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Highly prevalent TERT promoter mutations in aggressive thyroid cancers
- (2013) Xiaoli Liu et al. ENDOCRINE-RELATED CANCER
- Frequent SomaticTERTPromoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
- (2013) Iñigo Landa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
- (2013) Pedro Castelo-Branco et al. LANCET ONCOLOGY
- The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
- (2013) T Liu et al. ONCOGENE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- Regulation of the human catalytic subunit of telomerase (hTERT)
- (2012) Michael Daniel et al. GENE
- Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells
- (2012) Z Liu et al. ONCOGENE
- Telomere Length and Telomerase Reverse Transcriptase Gene Copy Number in Patients with Papillary Thyroid Carcinoma
- (2011) Jaroslaw Jendrzejewski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Follicular thyroid neoplasm: clinicopathologic features suggesting malignancy
- (2010) ANNUKKA HEIKKILÄ et al. APMIS
- Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells
- (2008) Ying Cao et al. CANCER SCIENCE
- Short Telomeres, Telomerase Reverse Transcriptase Gene Amplification, and Increased Telomerase Activity in the Blood of Familial Papillary Thyroid Cancer Patients
- (2008) Marco Capezzone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started